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Ab s t r Ac t 
Fontan procedure, in which systemic circulation is redirected into pulmonary circulation by a baffle, is a palliative surgical strategy for patients 
born with single ventricle congenital heart disease. Hemodynamic changes secondary to Fontan procedure, also termed as Fontan physiology, 
result in end-organ damage, especially of the liver. Fontan-associated liver disease (FALD) represents a spectrum of pathologies ranging from 
mild liver fibrosis to advanced liver cirrhosis and hepatocellular carcinoma (HCC). Hepatic nodules, some of which have been documented as 
HCC in several case series and reports, are a recognized complicated feature of FALD. Herein, we report a case with benign hepatic nodules 
mimicking HCC by imaging characteristics, emphasizing the fact that arterially enhancing lesions with delayed washout appearance may reflect 
benign regenerative or focal nodular hyperplasia-like nodules in patients with Fontan physiology.
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In t r o d u c t I o n 
Fontan procedure, which was originally introduced in 1971 by 
Fontan and Baudet,1 is a palliative surgical operation for patients 
born with single ventricle congenital heart disease. This strategy 
redirects systemic venous blood flow directly to pulmonary 
circulation to minimize the oxygenated–deoxygenated blood 
mixture and alleviate the burden on a single ventricle,1 which 
consequently results in elevated central venous pressure and 
diminished cardiac output.2 These hemodynamic changes, also 
termed as Fontan physiology, cause end-organ damage throughout 
the body and thus present with some debilitating pathologies, such 
as peripheral venous insufficiency, plastic bronchitis, protein-losing 
enteropathy, and Fontan-associated liver disease (FALD).3,4
We present a case of FALD in an adult with histopathologically 
proven benign nodules mimicking hepatocellular carcinoma (HCC) 
by imaging criteria. Arterially enhancing benign hepatic nodules 
with a washout appearance on both portal and more delayed 
venous phase images are rare, with very few scattered case reports 
throughout the English literature to date.5 Large-scale studies are 
needed to overcome the limitations of rare case reports.
cA s e de s c r I p t I o n 
A 37-year-old woman was referred to our ultrasonography (US) 
department with right upper quadrant pain. She had a history 
of pulmonary atresia with complex univentricular anatomy. 
She underwent five aortopulmonary shunt operations in early 
childhood, followed by classic Fontan operation at ten years of 
age (Fig. 1). She was on amiodarone and aspirin for atrial flutter. 
The blood test results on admission were unremarkable. Hepatitis 
B and C virus serologies were negative, and there was no history 
of alcohol abuse. She had not been under any hepatic surveillance 
and had not undergone any hepatic imaging previously. Physical 
examination revealed abdominal tenderness in epigastrium and 
right upper quadrant with palpation.
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Fig. 1: Anteroposterior chest radiograph shows a median sternotomy 
defect due to previous open-heart surgery and mild cardiomegaly with 
epicardial pacer/leads
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Grayscale and Doppler US examinations showed cirrhotic 
features, consistent with FALD. Additionally, several hypervascular 
liver lesions were found with a dominant lesion in segment 7 
concerning HCC in the cirrhotic background (Fig. 2). However, 
serum alpha-fetoprotein level was within the normal range. 
Triphasic computed tomography (CT) of the liver was subsequently 
performed to further evaluate these findings on US. The lesion in 
question showed enhancement during the arterial phase, followed 
by washout during the portal and late venous phases (Fig. 3). Given 
the past medical history and radiological findings, US-guided 
Figs 2A and B: Grayscale (A) and color Doppler (B) US images demonstrate a well-circumscribed, hypervascular hepatic nodule (arrows) in segment 7
Figs 3A to C: Axial contrast-enhanced CT images reveal avid enhancement of the dominant nodule (arrows) during the late arterial phase (A) with 
a washout appearance during the portal (B) and more delayed (C) venous phases. Note that other arterially enhancing liver nodules do not show 
any absolute washout on delayed phase images
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biopsy was performed from the dominant lesion. The biopsy 
revealed sinusoidal dilatation and focal fibrosis without any features 
concerning malignancy. On follow-up examination, hepatic lesions 
showed size stability over 12 months, and thus benign etiology was 
favored. At the time of this case report, the patient is doing well on 
a routine follow-up program for FALD.
dI s c u s s I o n 
Fontan-associated liver disease refers to a spectrum of pathologies 
of the liver secondary to hemodynamic changes associated 
with Fontan physiology. Elevated central venous pressure and 
diminished cardiac output lead to hepatic venous congestion, 
ischemia, and eventually fibrosis.6 The histological features in 
the liver of patients with Fontan physiology are similar to those 
seen in congestive heart failure.7 Histological studies also show 
that almost half of the patients have developed advanced liver 
cirrhosis within 30 years after the Fontan procedure.8 In most 
of the patients with Fontan physiology, liver fibrosis is further 
complicated by hepatic nodules, some of which were proved 
to be HCC throughout the literature.3–5,9–18 However, arterially 
enhancing benign hepatic nodules in this patient population 
may demonstrate washout on portal venous and/or more delayed 
phase images, as in our case.5 Hence, not all arterially enhancing 
nodules with a washout appearance on portal venous and/or more 
delayed phase images can be considered malignant. Although 
the underlying mechanism has not yet been elucidated clearly, 
these findings are postulated to be secondary to hemodynamic 
changes associated with Fontan physiology. Radiologists should 
consider histological confirmation before making the definitive 
diagnosis of HCC by imaging criteria.
co n c lu s I o n 
Fontan-associated liver disease is an inevitable consequence of the 
Fontan procedure. In this patient population, arterially enhancing 
benign hepatic nodules with delayed washout pose a diagnostic 
challenge since these enhancement features overlap with HCC. 
Both radiologists and hepatologists should be aware of this benign 
complication not to misdiagnose these nodules as HCC. In FALD 
patients, all arterially enhancing hepatic nodules with delayed 
washout should be approached with caution, which may require 
follow-up imaging to document stability or biopsy if clinically 
indicated.
et h I c s co m m I t t e e Ap p r ovA l 
The Institutional Review Board (IRB) approved this study.
In f o r m e d co n s e n t 
The requirement for the informed consent was waived since all the 
content herein has been fully deidentified.
fI n A n c I A l dI s c lo s u r e 
This research received no direct funding. However, Dr Tirkes is 
supported by the National Cancer Institute and National Institute 
of Diabetes and Digestive and Kidney Diseases of the National 
Institutes of Health under award numbers 1R01DK116963 and 
U01DK108323 (Consortium for the Study of Chronic Pancreatitis, 
Diabetes, and Pancreatic Cancer). The content is solely the 
responsibility of the authors and does not necessarily represent 
the official views of the National Institutes of Health.
not e 
All the contents herein have been fully deidentified to protect the 
patient’s privacy.
re f e r e n c e s
 1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 
1971;26(3):240–248. DOI: 10.1136/thx.26.3.240.
 2. Davies RR, Chen JM, Mosca RS. The Fontan procedure: evolution 
in technique; attendant imperfections and transplantation for 
“failure”. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 
2011;14(1):55–66. DOI: 10.1053/j.pcsu.2011.01.014.
 3. Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver 
disease: A review. J Cardiol 2019;74(3):223–232. DOI: 10.1016/ 
j.jjcc.2019.02.016.
 4. Tellez L, Rodriguez de Santiago E, Albillos A. Fontan-associated liver 
disease. . Rev Esp Cardiol (Engl Ed) 2018;71(3):192–202. DOI: 10.1016/ 
j.recesp.2017.10.014.
 5. Wells ML, Hough DM, Fidler JL, et al. Benign nodules in post-
Fontan livers can show imaging features considered diagnostic for 
hepatocellular carcinoma. Abdom Radiol (NY) 2017;42(11):2623–2631. 
DOI: 10.1007/s00261-017-1181-9.
 6. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and 
the liver. Hepatology 2012;56(3):1160–1169. DOI: 10.1002/hep.25692.
 7. Kendall TJ, Stedman B, Hacking N, et al. Hepatic fibrosis and cirrhosis 
in the Fontan circulation: a detailed morphological study. J Clin Pathol 
2008;61(4):504–508. DOI: 10.1136/jcp.2007.052365.
 8. Pundi K, Pundi KN, Kamath PS, et al. Liver disease in patients after the 
Fontan operation. Am J Cardiol 2016;117(3):456–460. DOI: 10.1016/j.
amjcard.2015.11.014.
 9. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients 
undergoing the Fontan procedure: Chronic passive congestion, 
cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. 
J Thorac Cardiovasc Surg 2005;129(6):1348–1352. DOI: 10.1016/j.
jtcvs.2004.10.005.
 10. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after 
the Fontan procedure. N Engl J Med 2013;368(18):1756–1757. DOI: 
10.1056/NEJMc1214222.
 11. Elder RW, Parekh S, Book WM. More on hepatocellular carcinoma after 
the Fontan procedure. N Engl J Med 2013;369(5):490. DOI: 10.1056/
NEJMc1306854.
 12. Kwon S, Scovel L, Yeh M, et al. Surgical management of hepatocellular 
carcinoma after Fontan procedure. J Gastrointest Oncol 2015;6(3): 
E55–E60.
 13. Yamada K, Shinmoto H, Kawamura Y, et al. Transarterial embolization 
for pediatric hepatocellular carcinoma with cardiac cirrhosis. Pediatr 
Int 2015;57(4):766–770. DOI: 10.1111/ped.12619.
 14. Takuma Y, Fukada Y, Iwadou S, et al. Surgical resection for 
hepatocellular carcinoma with cardiac cirrhosis after the Fontan 
procedure. Intern Med. 2016;55(22):3265–3272. DOI: 10.2169/
internalmedicine.55.6869.
 15. Oh C, Youn JK, Han JW, et al. Hepatocellular carcinoma after the 
Fontan procedure in a 16-year-old girl: A case report. Medicine 
(Baltimore) 2016;95(41):e4823. DOI: 10.1097/MD.0000000000004823.
 16. Josephus Jitta D, Wagenaar LJ, Mulder BJ, et al. Three cases of 
hepatocellular carcinoma in Fontan patients: Review of the literature 
and suggestions for hepatic screening. Int J Cardiol 2016;206:21–26. 
DOI: 10.1016/j.ijcard.2015.12.033.
 17. Conroy MR, Moe TG. Hepatocellular carcinoma in the adult 
Fontan patient. Cardiol Young. 2017;27(2):407–409. DOI: 10.1017/
S1047951116001360.
 18. Martinez-Quintana E, Monescillo A, Rodriguez-Gonzalez F. 
Hepatocellular carcinoma in a non-failing Fontan circulation. Rev 
Esp Enferm Dig 2017;109(5):375.
